Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve

被引:9
|
作者
Niioka, Takenori
Yasui-Furukori, Norio [1 ]
Uno, Tsukasa
Sugawara, Kazunobu
Kaneko, Sunao
Tateishi, Tomonori
机构
[1] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Sch Med, Dept Clin Pharmacol, Hirosaki, Aomori 0368562, Japan
[3] Hirosaki Univ Hosp, Dept Pharm, Hirosaki, Aomori 0368562, Japan
关键词
lansoprazole; AUC; single time-point; CYP2C19; genotype; phenotype;
D O I
10.1097/01.ftd.0000211835.18973.e3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The objective of this study was to identify a single time-point for plasma lansoprazole measurement that adequately reflects area under the plasma lansoprazole concentration-time curve (AUC) after administration of lansoprazole alone or together with coadministration with CYP mediators. A randomized double-blind placebo-controlled crossover study design in 3 phases was conducted at intervals of 2 weeks. Eighteen healthy Japanese volunteers, comprising 3 CYP2C19 genotype groups, took a single oral 60-mg dose of lansoprazole after three 6-day pretreatments, that is, clarithromycin 800 mg/d, fluvoxamine 50mg/d, and placebo. Blood samplings (10 mL each) for determination of lansoprazole were taken up to 24 hours after the administration of lansoprazole. Correlation between plasma lansoprazole concentrations at various time points and AUC(0-24) were analyzed. Although there were significant differences in the pharmacokinetic parameters of lansoprazole during clarithromycin and placebo among CYP2C19 genotypes, the differences were not found during fluvoxamine. The plasma concentrations 3, 4, 6, and 8 hours after administration (C3, C4, C6, and C8, respectively) were highly correlated with AUC(0-24) in coadministration with placebo, clarithromycin, and fluvoxamine (r > 0.8, P < 0.001). In particular, C6 showed a correlation coefficient of 0.940, 0.992, and 0.953 in coadministration with placebo, clarithromycin, and fluvoxamine, respectively, and was the most appropriate for estimating AUC(0-24). The present study demonstrates that AUC of lansoprazole can be estimated by using a single time-point at C6. This method of plasma concentration monitoring at one time-point might be more suitable for AUC estimation than reference to CYP2CI9 genotypes, particularly in coadministration of CYP mediators.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 50 条
  • [1] Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve
    Niioka, Takenori
    Uno, Tsukasa
    Yasui-Furukori, Norio
    Shimizu, Mikiko
    Sugawara, Kazunobu
    Tateishi, Tomonori
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (10) : 855 - 861
  • [2] Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve
    Takenori Niioka
    Tsukasa Uno
    Norio Yasui-Furukori
    Mikiko Shimizu
    Kazunobu Sugawara
    Tomonori Tateishi
    European Journal of Clinical Pharmacology, 2006, 62 : 855 - 861
  • [3] Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers
    Niioka, Takenori
    Miura, Masatomo
    Uno, Tsukasa
    Yasui-Furukori, Norio
    Hayakari, Makoto
    Tateishi, Tomonori
    Suzuki, Toshio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (05) : 503 - 509
  • [4] Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers
    Takenori Niioka
    Masatomo Miura
    Tsukasa Uno
    Norio Yasui-Furukori
    Makoto Hayakari
    Tomonori Tateishi
    Toshio Suzuki
    European Journal of Clinical Pharmacology, 2008, 64 : 503 - 509
  • [5] INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE
    HARRIS, PA
    RIEGELMA.S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (01) : 71 - &
  • [6] CONSTANT BLOOD WITHDRAWAL METHOD FOR AREA UNDER PLASMA CONCENTRATION-TIME CURVE
    KOWARSKI, CR
    KOWARSKI, AA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (06) : 875 - 876
  • [7] A Limited Sampling Strategy for Estimation of the Area Under the Plasma Concentration-Time Curve of Gefitinib
    Miura, Masatomo
    Sato, Kazuhiro
    Miura, Hajime
    Niioka, Takenori
    Kobayashi, Hiroyuki
    Narita, Chihiro
    Ito, Hiroshi
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 24 - 29
  • [8] Limited sampling strategy for determining metformin area under the plasma concentration-time curve
    Santoro, Ana Beatriz
    Stage, Tore Bjerregaard
    Struchiner, Claudio Jose
    Hougaard Christensen, Mette Marie
    Brosen, Kim
    Suarez-Kurtz, Guilherme
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (04) : 1002 - 1010
  • [9] PHARMACOKINETIC BASIS FOR INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE
    GIBALDI, M
    FELDMAN, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (12) : 1477 - &
  • [10] Appropriateness of basing vancomycin dosing on area under the concentration-time curve
    Dalton, Bruce R.
    Dersch-Mills, Deonne
    Langevin, Ashten
    Sabuda, Deana
    Rennert-May, Elissa
    Griener, Thomas
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (21) : 1718 - 1721